论文信息 - Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial - 字舞流文

Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial

Xin Hu | C. Verschraegen | Z. Shao | Yi Xiao | Lin Jiang | Xiaoyu Zhu | V. Kaklamani | Zhonghua Wang | D. Stover | Yizhou Jiang | D. Ma | J. Zou | W. Zuo | Y. Liu | Jiahan Ding